Intraday Trading Highlights
The stock opened with a notable gap up of 2.47%, signalling strong buying interest from the outset. Throughout the trading session, Unichem Laboratories Ltd maintained upward momentum, ultimately reaching an intraday peak of Rs 408, representing an 8.9% rise from its previous close. This intraday high marks a continuation of the stock’s positive trend, as it has now recorded gains for two consecutive days, accumulating an 8.97% return over this period.
In comparison, the Pharmaceuticals & Drugs sector advanced by 2.86% on the same day, underscoring Unichem’s outperformance by 5.93 percentage points. The broader Sensex index, despite opening sharply higher by 3,656.74 points, retreated to close down by 1,277.33 points, ending the day at 84,045.87 – a 2.91% decline. This divergence highlights the stock’s relative strength amid a volatile market backdrop.
Technical Positioning and Moving Averages
From a technical perspective, Unichem Laboratories Ltd’s current price stands above its 5-day and 20-day moving averages, indicating short-term bullish momentum. However, it remains below the 50-day, 100-day, and 200-day moving averages, suggesting that medium- and long-term trends have yet to fully align with the recent gains. This mixed technical picture reflects the stock’s ongoing recovery phase within a broader downtrend context.
Meanwhile, the Sensex is trading below its 50-day moving average, although the 50-day average remains above the 200-day average, signalling a still intact longer-term uptrend for the benchmark index. Mega-cap stocks led the market rally earlier in the session, but the overall market lost momentum as the day progressed.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
Performance Metrics and Market Capitalisation
Unichem Laboratories Ltd currently holds a Mojo Score of 40.0 and a Mojo Grade of Sell, having been downgraded from Hold on 22 Jul 2025. The company’s market capitalisation grade stands at 3, reflecting its mid-tier valuation within the Pharmaceuticals & Biotechnology sector.
Examining recent performance trends, the stock has delivered mixed results over various time frames. While it has gained 9.28% over the past week, it has declined by 9.32% over the last month and 15.28% over three months. Year-to-date, the stock is down 8.93%, underperforming the Sensex’s 1.43% decline. Over the longer term, Unichem has lagged the benchmark, with a one-year return of -43.70% compared to Sensex’s 8.83%, and a five-year return of 27.60% versus Sensex’s 67.15%.
Sector and Market Context
The Pharmaceuticals & Biotechnology sector, in which Unichem operates, has shown moderate gains of 2.86% on the day, supported by selective buying interest. Despite the broader market’s retreat, the sector’s relative strength has been a key factor in Unichem’s outperformance. The stock’s ability to outperform both its sector and the Sensex during a day of market volatility highlights its current trading resilience.
Unichem Laboratories Ltd or something better? Our SwitchER feature analyzes this small-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Summary of Trading Action
Unichem Laboratories Ltd’s strong intraday performance on 3 Feb 2026 was characterised by a decisive gap up opening, sustained buying pressure, and a peak price of Rs 408. The stock’s gains outpaced both its sector and the broader market, which experienced a late-session pullback. The two-day consecutive rise and the stock’s position relative to short-term moving averages indicate a positive trading momentum in the near term.
While the stock remains below its longer-term moving averages, the current price action suggests a phase of recovery within a broader context of recent underperformance. Investors and market participants will likely monitor whether this momentum can be sustained amid ongoing sector and market dynamics.
Market Snapshot
On the same day, the Sensex traded at 84,045.87, down 2.91%, and remained 2.51% below its 52-week high of 86,159.02. Mega-cap stocks led the initial rally, but the index lost ground as the session progressed. Unichem’s relative strength amid this environment underscores its distinct trading pattern compared to the broader market.
Conclusion
Unichem Laboratories Ltd’s intraday high of Rs 408 and 7.29% gain on 3 Feb 2026 reflect a strong trading session marked by significant outperformance within the Pharmaceuticals & Biotechnology sector. The stock’s upward momentum over the past two days and its relative strength against the Sensex highlight its current market positioning amid a fluctuating broader market.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
